(1 - 8 from 8
)
First-line nivolumab-ipilimumab combination improves OS in ...
www.healio.com
Aug 10, — Paul Baas, MD, researcher at Netherlands Cancer Institute and University of Leiden in Amsterdam, presented the results during the ... › news › hematology-oncology
History of Changes for Study: NCT ClinicalTrials.gov
clinicaltrials.gov
Contact:Principal Investigator: Paul Baas. Spain. Vall d'Hebron University Hospital [Recruiting] Barcelona, Spain Contact:Contact: Marta Malo Perez + › history › NCT
Dr P. Baas - University of Amsterdam
www.uva.nl
Paul Baas focuses his attention as a tutor and head of the NKI-AVL’s Department of Thoracic Oncology on the development of new therapies and the treatment of lung cancer and malignant mesothelioma. As part of the collaboration with the AMC, ...
sorted by relevance / date